INVASIVE SARCOMATOID UROTHELIAL CARCINOMA

Clinical trials for INVASIVE SARCOMATOID UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new INVASIVE SARCOMATOID UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for INVASIVE SARCOMATOID UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists test Triple-Threat drug combo against Tough-to-Treat cancers

Disease control Ongoing

This early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…

Matched conditions: INVASIVE SARCOMATOID UROTHELIAL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

INVASIVE SARCOMATOID UROTHELIAL CARCINOMA

Get alerted when new INVASIVE SARCOMATOID UROTHELIAL CARCINOMA trials appear

Scientists test Triple-Threat drug combo against Tough-to-Treat cancers